Navigation Links
ANCA Antibodies (MPO/PR3) by ELISA

ProductsANCA Antibodies (MPO/PR3) by ELISA
Company ARUP Laboratories
Item ANCA Antibodies (MPO/PR3) by ELISA
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Anti-GBM Antibodies ELISA
2. Sm/RNP Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
3. SS-B (La) Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
4. Sm Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
5. SS-A (Ro)Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
6. Adenovirus Antibodies, IgG & IgM
7. Anti-Cardiolipin Antibodies, IgG & IgM
8. Anti-GBM Antibodies, IgA & IgG (IFA)
9. Anti-Glomerular Basement Membrane Antibodies, IgA & IgG
10. Anti-Neuronal Cell Antibodies, Serum
11. Anti-Neutrophil Cytoplasmic Antibodies Panel, IgG
Breaking Medicine Technology:Cambridge Scientists Archive 500,000th Crystal Structure 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8NeoGenomics to Present at the Rodman 26 Renshaw Healthcare Investment Conference on September 10 2009 13849 1NeoGenomics to Present at the Rodman 26 Renshaw Healthcare Investment Conference on September 10 2009 13849 2High School Sports Put Players at Risk for Severe Injuries 56218 1High School Sports Put Players at Risk for Severe Injuries 56218 2Spherix Incorporated to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13847 1Spherix Incorporated to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13847 2